Scientists reveal that a vaccine to combat hay fever is on the cards after trials on humans showed that they could reduce symptoms by a quarter over two years.
Rudolf Valenta, who led the research at the Medical University of Vienna said, “In the last study, still unpublished, we reach up to 60% [relief] for certain patients after one year treatment. It is likely that we can make them symptom-free after longer treatment. The planned schedule is five pre-seasonal injections before the pollen season of the first year and one daily refreshment every year.”
A follow-on study will start next year.
